Abstract
The point mutation at bp 8993 of human mtDNA in the ATPase 6 gene is associated with neurogenic weakness, ataxia and retinitis pigmentosa, and with subacute necrotizing encephalomyelopathy (Leigh disease) when present at high copy number. In this study we describe three new multiplex families with the ATPase 8993 mtDNA mutation and demonstrate a correlation between the percentage heteroplasmy of this mutation and the clinical phenotype. By combining this study with previous data we produce a graph of age of onset of symptoms versus percentage heteroplasmy of the mutation. Finally, we determine that ATP synthesis with NAD-linked substrates in cultured lymphoblast mitochondria from three patients with Leigh disease who had a high percentage heteroplasmy was on average 66% of the rate seen in control lymphoblast mitochondria. Similar rates are observed in lymphoblast mitochondria isolated from patients with Leigh disease due to complex I deficiency. This percentage appears to be independent of the rate of electron transport in mitochondria from patient cell lines with the mtDNA 8993 mutation.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Holt IJ, Harding AE, Morgan-Hughes JA: A new disease associated with mitochondrial DNA heteroplasmy. Am J Hum Genet 1990;46:428–433
Tatuch Y, Christodoulou J, Feigenbaum A, Clarke JTR, Wherret J, Smith C, Rudd N, Petrova-Benedict R, Robinson BH: Heteroplasmic mtDNA mutation (T→G) at 8993 can cause Leigh disease when the percentage of abnormal mtDNA is high. Am J Hum Genet 1992;50:852–858
Harding AE, Holt IJ, Sweeney MG, Brockington M, Davis MB: Prenatal diagnosis of mitochondrial DNA8993 T-G disease. Am J Hum Genet 1992;50:629–633
Shoffner JM, Fernhoff PM, Krawiecki NS, Caplan DB, Holt PJ, Wallace DC: Subacute necrotizing encephalopathy: Oxidative phosphorylation defects and the ATPase 6 mutation. Neurology 1992;42:2168–2174
Yoshinaga H, Ogino T, Ohtahara S, Sakuta R, Nonaka I, Horai S: A T to G mutation at nucleotide pair 8993 in mitochondrial DNA in a patient with Leigh syndrome. J Child Neurol 1993;8:129–133
Walsh PS, Metzger DA, Higuchi R: Rapid DNA Extraction. Biotechniques 1991; 10:506.
Old JM: Fetal DNA analysis; in Dories KE (ed): Human Genetic Diseases: A Practical Approach. Oxford, IRL, 1986.
Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT, Mullis KB: Primer dictated enzymatic amplification of DNA with a thermostable DNA polymerase. Science 1988;239:487–494
Robinson BH, Ward J, Goodyear P, Baudet A: Respiratory chain defects in the mitochondria of cultured skin fibroblasts from patients with lacticacidemia. J Clin Invest 1986;77:1422–1427
Bourgeron T, Chretien D, Rotig A, Munnich A, Rustin P: Isolation and characterization of mitochondria from human B lymphoblastoid cell lines. Biochem Biophys Res Commun 1992;186:16–23
Williamson JR, Corkey B: Assay of intermediates of the citric acid cycle and related compounds by fluorometric enzyme methods. Methods Enzymol 1969;13:434–513
Das AM, Harris DA: Defects in regulation of mitochondrial ATP synthase in cardiomyocytes from spontaneously hypertensive rats. Am J Physiol 1990;259:H1264–H1269
Bartlett GR: Phosphorous assay in column chromatography. J Biol Chem 1959;234:466–468
Ciafaloni E, Ricci E, Shanske S, et al: MELAS: Clinical features, biochemistry and molecular genetics. Ann Neurol 1992;31:391–398
Ciafaloni E, Santorelli FM, Shankse S, Deonna I, Rowlet E, et al: Maternally inherited Leigh syndrome. J Pediatr 1992;122:419–422
Glerum M, Robinson BH, Spratt C, Wilson J, Patrick D: Abnormal kinetic behaviour of cytochrome oxidase in a case of Leigh disease. Am J Hum Genet 1987;41:584–593
Robinson BH, Glerum DM, Chow W, Petrova-Benedict R, Lightowlers R, Capaldi R: The use of skin fibroblast cultures in the detection of respiratory chain defects in patients with lacticacidemia. Pediatr Res 1990;28:549–555
Letellier T, Molgat M, Mozat JP: Control of oxidative phosphorylation in rat muscle mitochondria: Implications for mitochondrial myopathies. Biochim Biophys Acta 1993;1141:58–64
Hartzog PE, Cain BD: The a Leu 207 → Arg mutation in F1F0-ATP synthase from Escherichia coli. J Biol Chem 1993;268:12250–12252.
Filiingame RH: Subunit c of F1F0 ATP synthase: Structure and role in transmembrane energy transduction. Biochim Biophys Acta 1992;1101:240–243
Acknowledgements
We thank the Canadian National Centres of Excellence Programme for supporting this work.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tatuch, Y., Pagon, R.A., Vlcek, B. et al. The 8993 mtDNA Mutation: Heteroplasmy and Clinical Presentation in Three Families. Eur J Hum Genet 2, 35–43 (1994). https://doi.org/10.1159/000472339
Received:
Revised:
Accepted:
Issue date:
DOI: https://doi.org/10.1159/000472339
Key Words
This article is cited by
-
Is the spinal cord truly affected in half of the patients with Kearns-Sayre syndrome?
Neuroradiology (2020)
-
Patient-derived lymphoblastoid cell lines harboring mitochondrial DNA mutations as tool for small molecule drug discovery
BMC Research Notes (2018)
-
NARP-MILS syndrome caused by 8993 T > G mitochondrial DNA mutation: a clinical, genetic and neuropathological study
Acta Neuropathologica (2006)
